Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema.

Ali Demircan Zeynep Alkin Ceren YesilkayaGokhan DemirBurcu Kemer

Published in: Journal of ophthalmology (2018)

Both aflibercept and ranibizumab decreased CMT in patients with persistent DME who showed a poor response to ranibizumab injections. However, switching to aflibercept provided only morphologic improvement.

Keyphrases

age related macular degeneration
diabetic retinopathy
ultrasound guided
endothelial cells
optical coherence tomography